📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: CancerGene

1.1 - Company Overview

CancerGene Logo

CancerGene

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of an evolving healthcare science platform for hereditary cancer risk assessment, advancing pedigree generation and risk modeling and bringing increasingly powerful connections to thousands of patients and practices.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to CancerGene

Emids Logo

Emids

HQ: United States Website
  • Description: Provider of digital transformation and IT consulting solutions to the healthcare industry, serving payers, providers, life sciences, and technology firms. Offerings include EPulseAI generative AI, design-led engineering, data engineering and analytics, automation, and healthcare core platforms to improve patient outcomes, productivity, and operational efficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Emids company profile →
Payer Sciences Logo

Payer Sciences

HQ: United States Website
  • Description: Provider of data-and-analytics-driven health marketing and market access solutions that uncover real-time payer insights to inform localized strategies and communications. Offerings include PTO for prescriber-level access messaging, AMP for account manager support, AIM dashboards, VOLT evidence categorization for value messaging, n1Connect nonpersonal promotion, and custom technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Payer Sciences company profile →
TeraMedica Logo

TeraMedica

HQ: United States Website
  • Description: Provider of vendor-neutral, enterprise-wide solutions for unrestricted medical image management. Offers Synapse VNA, a vendor-neutral archive that manages and connects DICOM and non-DICOM content across healthcare systems, supporting modern industry standards, and Connext Workflow Solutions, which automates capture and association of multimedia with patient records and integrates with electronic health records.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TeraMedica company profile →
RxLive Logo

RxLive

HQ: United States Website
  • Description: Provider of a telehealth platform where clinical pharmacists deliver comprehensive medication management services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RxLive company profile →
Datavant Logo

Datavant

HQ: United States Website
  • Description: Provider of secure health data connectivity and privacy solutions, including Datavant Connect to link and share health data across sources with regulatory compliance, and Privacy Hub to simplify de-identification, tokenization, and dataset management to protect patient privacy and improve data connectivity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Datavant company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for CancerGene

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to CancerGene

2.2 - Growth funds investing in similar companies to CancerGene

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for CancerGene

4.2 - Public trading comparable groups for CancerGene

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to CancerGene

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About CancerGene

What does CancerGene do?

CancerGene is a provider of an evolving healthcare science platform for hereditary cancer risk assessment, advancing pedigree generation and risk modeling and bringing increasingly powerful connections to thousands of patients and practices.

Who are CancerGene's competitors?

CancerGene's competitors and similar companies include Emids, Payer Sciences, TeraMedica, RxLive, and Datavant.

Where is CancerGene headquartered?

CancerGene is headquartered in United States.

How many employees does CancerGene have?

CancerGene has 1,000 employees 🔒.

When was CancerGene founded?

CancerGene was founded in 2010 🔒.

What sector and industry vertical is CancerGene in?

CancerGene is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for CancerGene

Who are the top strategic acquirers in CancerGene's sector and industry

Top strategic M&A buyers and acquirers in CancerGene's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for CancerGene?

Top strategic M&A buyers groups and sectors for CancerGene include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in CancerGene's sector and industry vertical

Which are the top PE firms investing in CancerGene's sector and industry vertical?

Top PE firms investing in CancerGene's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in CancerGene's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in CancerGene's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in CancerGene's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to CancerGene include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in CancerGene's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for CancerGene?

The key public trading comparables and valuation benchmarks for CancerGene include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for CancerGene for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for CancerGene with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in CancerGene's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for CancerGene with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in CancerGene's' sector and industry vertical?

Access recent funding rounds and capital raises in CancerGene's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for CancerGene